Gopalan Sethuraman, PhD

Associate Professor of Research Neurology

Publications

A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer’s disease Stat Med. 2018 09 20; 37(21):3047-3055.

Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study Alzheimers Res Ther. 2018 04 03; 10(1):36.

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer’s disease patients Alzheimers Dement. 2016 Feb; 12(2):110-120.

Delayed-start analysis: Mild Alzheimer’s disease patients in solanezumab trials, 35 years. Alzheimers Dement (N Y). 2015 Sep; 1(2):111-121.

Adverse events and dropouts in Alzheimer’s disease studies: what can we learn? Alzheimers Dement. 2015 Jan; 11(1):24-31.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.